Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV‐1 protease, reverse transcriptase, and integrase inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2825|32|1|jcla.22206-jcla.22206

ISSN： 0887-8013

Source： Journal Of Clinical Laboratory Analysis (Electronic), Vol.32, Iss.1, 2018-01, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors from Natural Products to HIV-1 Reverse Transcriptase, Protease and Integrase

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-12 ,pp. : 1331-1344

Bentham Science Publishers

Access to resources Recommend Favorite

Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4039-4053

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of HIV-1 Reverse Transcriptase and Integrase: Classical and Emerging Therapeutical Approaches

By  

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 595-614

Bentham Science Publishers

Access to resources Recommend Favorite

Peptides as New Inhibitors of HIV-1 Reverse Transcriptase and Integrase

By  

Current Medicinal Chemistry, Vol. 10, Iss. 18, 2003-09 ,pp. : 1765-1778

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören   Hilgeroth Andreas  

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite